远程监测自动化腹膜透析降低死亡率、不良事件与住院率:一项整群随机对照试验
该整群随机对照试验将21家医院分配至远程监测自动化腹膜透析(RM-APD)组(10家医院,403例)或传统APD组(11家医院,398例),随访中位9.5个月。结果显示RM-APD组全因死亡率、心血管死亡率及心血管病、液体超负荷或透析不充分相关的不良事件和住院率均低于传统APD组。
要点
- RM-APD可减少心血管病、液体超负荷或透析不充分相关的不良事件和住院。
核心结论
- 远程监测可为自动化腹膜透析带来显著优势,包括改善生存率、降低不良事件和住院率,有利于该疗法的接受和推广。
研究设计与样本
- 整群随机、开放标签、对照试验,21家具备APD项目的医院被分配至RM-APD组(10家医院,403例)或传统APD组(11家医院,398例),治疗开始腹膜透析的成人患者,随访中位9.5个月。
主要发现
- 复合指数1(全因死亡、首次不良事件和任何原因住院)达到时间两组无差异。
临床怎么用
- 对于开始腹膜透析的成人患者,采用RM-APD可能改善生存并减少不良事件和住院。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Remote monitoring (RM) of patients on automated peritoneal dialysis (APD) prevents complications and improves treatment quality. We analyzed the effect of RM-APD on mortality and complications related to cardiovascular disease, fluid overload and insufficient dialysis efficiency. METHODS: In a cluster-randomized, open-label, controlled trial, 21 hospitals with APD programs were assigned to use either RM-APD (10 hospitals; 403 patients) or conventional APD (11 hospitals; 398 patients) for the treatment of adult patients starting PD. Primary outcomes were time to first event of: (i) Composite Index 1 comprising all-cause mortality, first adverse events and hospitalizations of any cause, and (ii) Composite Index 2 comprising cardiovascular mortality, first adverse event and hospitalizations related to cardiovascular disease, fluid overload and insufficient dialysis efficiency. Secondary outcomes were time to first event of individual components of the two composite indices, and rates of adverse events, hospitalizations, unplanned visits and transfer to hemodialysis. Patients were followed for a median of 9.5 months. Primary outcomes were evaluated by competing risk analysis and restricted mean survival time (RMST) analysis. RESULTS: While time to reach Composite Index 1 did not differ between the groups, Composite Index 2 was reached earlier (ΔRMST: -0.86 months; P = .02), and all-cause mortality [55 vs 33 deaths, P = .01; sub-hazard ratio (sHR) 1.69 (95% confidence interval 1.39-2.05), P < .001] and hospitalizations of any cause were higher in APD group than in RM-APD as were cardiovascular deaths [24 vs 13 deaths, P = .05; sHR 2.44 (95% confidence interval 1.72-3.45), P < .001] and rates of adverse events and hospitalizations related to cardiovascular disease, fluid overload or insufficient dialysis efficiency. Dropouts were more common in the APD group (131 vs 110, P = .048). CONCLUSIONS: This randomized controlled trial shows that RM may add significant advantages to APD, including improved survival and reduced rate of adverse events and hospitalizations, which can favorably impact the acceptance and adoption of the therapy.
引用
- Paniagua R, Ramos A, Ávila M, et al. Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events and hospitalizations: a cluster-randomized controlled trial. Nephrol Dial Transplant. 2025. PMID: 39165115. doi:10.1093/ndt/gfae188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。